Sign In
Buy VTR
$79.05
-1.10 (-1.37%)
At Close: Jun 03, 2026
Ventas Announces Pricing of an Underwritten Offering of 10.6 Million Shares of Common Stock
08:30am, Thursday, 14'th Nov 2024
CHICAGO--(BUSINESS WIRE)--Ventas, Inc. (NYSE: VTR) (“Ventas” or the “Company”) announced today that it priced an underwritten public offering of 10,600,000 shares of its common stock in connec
Ventas Announces Underwritten Offering of 10.6 Million Shares of Common Stock
04:47pm, Wednesday, 13'th Nov 2024
CHICAGO--(BUSINESS WIRE)--Ventas, Inc. (NYSE: VTR) (“Ventas” or the “Company”) announced today that it is commencing an underwritten public offering of 10,600,000 shares of its common stock in
Here's Why Ventas Stock is an Apt Portfolio Pick for Now
12:45pm, Tuesday, 12'th Nov 2024
Rising senior citizens' population and favorable outpatient visit trends are likely to benefit VTR.
Ventas: Growth Set To Continue In The Years Ahead
11:40am, Sunday, 10'th Nov 2024
Ventas is a healthcare REIT focused on senior housing, outpatient medical & research, and triple-net lease properties. The Q3 2024 results were solid and the company increased its normalized FFO midpo
MOBs, Office But No Need For Life Support
12:20am, Saturday, 02'nd Nov 2024
Unlike in traditional office, healthcare requires in-office interactions, which reduces the risk of ‘work from home'. Outpatient services are taking market share from inpatient (hospital) settings d
Ventas, Inc. (VTR) Q3 2024 Earnings Call Transcript
04:55pm, Thursday, 31'st Oct 2024
Ventas, Inc. (VTR) Q3 2024 Earnings Call Transcript
Ventas' Q3 FFO Meet Estimates on Higher Same-Store NOI, View Raised
02:50pm, Thursday, 31'st Oct 2024
VTR's Q3 results reflect a year-over-year rise in revenues. The total property same-store NOI improves on strong performance across the business segments.
Here's What Key Metrics Tell Us About Ventas (VTR) Q3 Earnings
07:01pm, Wednesday, 30'th Oct 2024
Although the revenue and EPS for Ventas (VTR) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wall Stree
Ventas (VTR) Q3 FFO Match Estimates
06:31pm, Wednesday, 30'th Oct 2024
Ventas (VTR) came out with quarterly funds from operations (FFO) of $0.80 per share, in line with the Zacks Consensus Estimate. This compares to FFO of $0.75 per share a year ago.
Healthcare REIT Ventas raises annual FFO per share forecast
05:43pm, Wednesday, 30'th Oct 2024
Healthcare REIT Ventas slightly raised the lower end of its annual funds from operations (FFO) forecast on Wednesday, expecting continued strong performance from its assisted living and senior housing
Ventas Reports 2024 Third Quarter Results
04:11pm, Wednesday, 30'th Oct 2024
CHICAGO--(BUSINESS WIRE)--Ventas, Inc. (NYSE: VTR) (“Ventas” or the “Company”) today reported results for the third quarter ended September 30, 2024. CEO Remarks “Ventas delivered another st
Stay Ahead of the Game With Ventas (VTR) Q3 Earnings: Wall Street's Insights on Key Metrics
10:21am, Monday, 28'th Oct 2024
Get a deeper insight into the potential performance of Ventas (VTR) for the quarter ended September 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for so
These REITs Trade At Discounts, But Should They?
09:39am, Sunday, 27'th Oct 2024
There are substantial valuation gaps among REIT sectors, with some justified by fundamentals and others representing mispricing, providing investment opportunities in undervalued sectors. Hotels and o
What's in the Offing for Ventas Stock This Earnings Season?
02:25pm, Friday, 25'th Oct 2024
VTR's Q3 earnings are likely to have benefited from favorable SHOP operating trends, healthy demand for life-science real estate assets and accretive investments.
Healthpeak's Q3 FFO Beats Estimates, Same-Store NOI Rises
12:01pm, Friday, 25'th Oct 2024
DOC's Q3 FFO tops estimates. Results reflect a year-over-year rise in revenues and total merger-combined same-store cash (adjusted) NOI.
